{"nctId":"NCT01988779","briefTitle":"Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations","startDateStruct":{"date":"2013-10","type":"ACTUAL"},"conditions":["Chronic Rhinosinusitis"],"count":33,"armGroups":[{"label":"oral placebo with nebulized intranasal levofloxacin","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: oral levofloxacin","Drug: nebulized levofloxacin"]},{"label":"oral antibiotics with nebulized intranasal placebo","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: oral levofloxacin","Drug: nebulized levofloxacin"]}],"interventions":[{"name":"oral levofloxacin","otherNames":[]},{"name":"nebulized levofloxacin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Adults (age â‰¥ 18).\n2. Diagnosis of CRS.\n3. Worsening sinonasal symptoms.\n4. Previous bilateral endoscopic sinus surgery (ESS) (including maxillary antrostomy and anterior ethmoidectomy).\n5. English speaking.\n6. Open sinuses (open middle meatus bilaterally; determined on endoscopy).\n7. Positive sinonasal culture (1+ or greater) with sensitivity to one of the pre-chosen antibiotic regimens.\n\nExclusion Criteria:\n\n1. Patients \\< 18 years of age.\n2. Treatment with systemic or topical antibiotics within the last 1 month.\n3. Pregnant women.\n4. Non-English speaking persons.\n5. Systemically ill at initial visit necessitating treatment prior to culture data.\n6. Allergies to chosen susceptible antibiotics.\n7. Sinonasal culture with less than 1+ growth.\n8. Multiple organisms grown on culture that are not sensitive to a single antibiotic.\n9. Patients with ciliary function disorders (cystic fibrosis, Kartagener's syndrome, ciliary dyskinesia).\n10. Patients with immunodeficiencies.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Rhinosinusitis Disability Index (RSDI) Score","description":"The Rhinosinusitis Disability Index is a 30-item questionnaire completed by the patient or subject. Each item has a value of zero to four, a higher score indicates a self-perception of worse symptoms. The minimum score is zero and the maximum score is 120.\n\nThe difference score here is the post-treatment score minus the pre-treatment score, with lower meaning more improvement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.000","spread":"29.47"},{"groupId":"OG001","value":"-14.82","spread":"13.49"}]}]}]},{"type":"SECONDARY","title":"Change in Sino-nasal Outcome Test (SNOT-22) Score","description":"The Sino-nasal outcome test is a 22-item questionnaire completed by the patient or subject. Each item has a value of zero to five, a higher score indicates a self-perception of worse symptoms. The minimum score is zero and the maximum score is 110.\n\nThe difference score here is the post-treatment score minus the pre-treatment score, with lower meaning more improvement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.333","spread":"33.02"},{"groupId":"OG001","value":"-18.73","spread":"12.37"}]}]}]},{"type":"SECONDARY","title":"Change in Bilateral Endoscopy Findings Using POSE Score","description":"The Perioperative Sinus Endoscopy (POSE) instrument is a specific tool to endoscopically assess the sinus cavities of patients who have undergone endoscopic sinus surgery.\n\nEach POSE score has a minimum of 0 and a maximum of 16, with a higher score indicating a worse outcome.\n\nHere, the Left and Right POSE scores are summed and the difference between baseline and the 14 day after treatment is reported.\n\nThe change in bilateral POSE score can in principle be -32 to +32, with increased scores indicating worse outcome and negative scores indicating improvement over the treatment period.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.889","spread":"5.442"},{"groupId":"OG001","value":"-4.545","spread":"2.806"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Post-treatment Culture Negativity","description":"Post-treatment culture negativity, defined as less than 1+ growth of organisms. A subject is counted '1' if both nares are free of bacterial growth, and '0' if growth is 1+ of more","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change in the Total Bacterial Community","description":"The bacterial community was determined using a 16S rRNA quantitative PCR processed using Quantitative Insights into Microbial Ecology (QIIME) software, version 1.8 to yield the number of operational taxonomic units in each subject sample. The count has a minimum of zero with an increasing score indicating a larger number of distinct bacterial species.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.40","spread":"9.530"},{"groupId":"OG001","value":"6.700","spread":"7.404"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":["epistaxis","bad taste","diarrhea","Fever","nausea/vomiting"]}}}